American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 672-682 , October 2008

Predictive Value of Nephelometric and High-Performance Liquid Chromatography Assays of Urine Albumin for Mortality in a High-Risk Aboriginal Population

  • Zaimin Wang, PhD

      Affiliations

    • Centre for Chronic Disease, School of Medicine, The University of Queensland, Brisbane
    • ,
  • Wendy E. Hoy, FRACP

      Affiliations

    • Centre for Chronic Disease, School of Medicine, The University of Queensland, Brisbane
    • Corresponding Author InformationAddress correspondence to Wendy E. Hoy, FRACP, Centre for Chronic Disease, School of Medicine, The University of Queensland, Royal Brisbane & Women's Hospital, Herston QLD 4029, Australia
    • ,
  • Jennifer L. Nicol, MSc

      Affiliations

    • Centre for Chronic Disease, School of Medicine, The University of Queensland, Brisbane
    • ,
  • Zhiqiang Wang, PhD

      Affiliations

    • Centre for Chronic Disease, School of Medicine, The University of Queensland, Brisbane
    • ,
  • Qing Su, PhD

      Affiliations

    • Department of Nephrology, Monash Medical Centre, Monash University, Melbourne, Australia
    • ,
  • Robert C. Atkins, FRACP

      Affiliations

    • Department of Nephrology, Monash Medical Centre, Monash University, Melbourne, Australia
    • ,
  • Kevan R. Polkinghorne, FRACP

      Affiliations

    • Department of Nephrology, Monash Medical Centre, Monash University, Melbourne, Australia

Received 11 October 2007 ,Revised 6 March 2008

References 

  1. Spencer J, Silva D, Hoy W. An epidemic of renal failure among Australian Aborigines. Med J Aust. 1998;168:537–541
  2. Cunningham J, Condon JR. Premature mortality in Aboriginal adults in the Northern Territory. Med J Aust. 1996;165:309–312
  3. Hoy WE, Wang Z, VanBuynder P, Baker PR, McDonald SM, Mathews JD. The natural history of renal disease in Australian Aborigines (Part 2. Albuminuria predicts natural death and renal failure). Kidney Int. 2001;60:249–256
  4. Cass A, Cunningham J, Wang Z, Hoy W. Regional variation in the incidence of end-stage renal disease in indigenous Australians. Med J Aust. 2001;175:24–27
  5. Wirta O, Pasternack A, Mustonen J, Laippala P. Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-dependent diabetic subjects. Nephrol Dial Transplant. 1997;12:2612–2617
  6. Hoy WE, Wang Z, Baker PR, Kelly AM. Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian Aboriginal community. Kidney Int Suppl. 2003;83:S66–S73
  7. Hoy W, McDonald SP. Albuminuria: Marker or target in indigenous populations. Kidney Int Suppl. 2004;92:S25–S31
  8. Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 1992;41:736–741
  9. Chen K, Chen C, Fuh M, Narayan K. Causes of death and associated factors among patients with noninsulin dependent diabetes mellitus in Taipei Taiwan. Diabetes Res Clin Pract. 1999;43:101–109
  10. Jager A, Kostense PJ, Ruhe HG, et al. Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: Five-year follow-up of the Hoorn Study. Arterioscler Thromb Vasc Biol. 1999;19:617–624
  11. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297–300
  12. Grimm RH, Svendsen KH, Kasiske B, Keane WF, Wahi MM. Proteinuria is a risk factor for mortality over 10 years of follow-up (MRFIT Research Group. Multiple Risk Factor Intervention Trial). Kidney Int Suppl. 1997;63:S10–S14
  13. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects (Islington Diabetes Survey). Lancet. 1988;2:530–533
  14. Jensen JS, Borch-Johnsen K, Feldt-Rasmussen B, Appleyard M, Jensen G. Urinary albumin excretion and history of acute myocardial infarction in a cross-sectional population study of 2,613 individuals. J Cardiovasc Risk. 1997;4:121–125
  15. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion (An independent predictor of ischemic heart disease). Arterioscler Thromb Vasc Biol. 1999;19:1992–1997
  16. Comper WD, Osicka TM, Jerums G. High prevalence of immuno-unreactive intact albumin in urine of diabetic patients. Am J Kidney Dis. 2003;41:336–342
  17. Osicka TM, Comper WD. Characterization of immunochemically nonreactive urinary albumin. Clin Chem. 2004;50:2286–2291
  18. Brinkman JW, Bakker SJ, Gansevoort RT, et al. Which method for quantifying urinary albumin excretion gives what outcome? (A comparison of immunonephelometry with HPLC). Kidney Int Suppl. 2004;92:S69–S75
  19. Clavant SP, Sastra SA, Osicka TM, Comper WD. The analysis and characterization of immuno-unreactive urinary albumin in healthy volunteers. Clin Biochem. 2006;39:143–151
  20. Comper WD, Osicka TM, Clark M, MacIsaac RJ, Jerums G. Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay. Kidney Int. 2004;65:1850–1855
  21. Polkinghorne KR, Su Q, Chadban SJ, Shaw JE, Zimmet PZ, Atkins RC. Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study: Immunonephelometry compared with high performance liquid chromatography. Am J Kidney Dis. 2006;47:604–613
  22. McQueen MJ, Gerstein HC, Pogue J, Mann JFE, Yusuf S. Reevaluation by high performance liquid chromatography: Clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study. Am J Kidney Dis. 2006;48:889–896
  23. Magliano DJ, Polkinghorne KR, Barr EL, et al. HPLC-detected albuminuria predicts mortality. J Am Soc Nephrol. 2007;18:3171–3176
  24. Hoy WE, Wang Z, VanBuynder P, Baker PR, Mathews JD. The natural history of renal disease in Australian Aborigines (Part 1. Changes in albuminuria and glomerular filtration rate over time). Kidney Int. 2001;60:243–248
  25. Wang Z, Hoy W. Association between diabetes and coronary heart disease in Aboriginal people: Are women disadvantaged?. Med J Aust. 2004;180:508–511
  26. Wang Z, Hoy W. Waist circumference, body mass index, hip circumference and waist-to-hip ratio as predictors of cardiovascular disease in Aboriginal people. Eur J Clin Nutr. 2004;58:888–893
  27. Wang Z, Hoy W. Albuminuria as a marker of the risk of developing type 2 diabetes in non-diabetic Aboriginal Australians. Int J Epidemiol. 2006;35:1331–1335
  28. Clogg CC, Petkova E, Haritou A. Statistical methods for comparing regression coefficients between models. Am J Sociol. 1995;100:1261–1293
  29. Mann JF, Yi QL, Gerstein HC. Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease. Kidney Int Suppl. 2004;92:S59–S62

 The field work to gather the baseline data was done while Dr Hoy was based at the Menzies School of Health Research, Darwin, NT, Australia.

 Originally published online as doi:10.1053/j.ajkd.2008.03.007 on June 26, 2008.

PII: S0272-6386(08)00580-5

doi: 10.1053/j.ajkd.2008.03.007

American Journal of Kidney Diseases
Volume 52, Issue 4 , Pages 672-682 , October 2008

Article Tools

* Image Usage & Resolution